Prognostic and Predictive Value of <i>LIV1</i> Expression in Early Breast Cancer and by Molecular Subtype

Prognostic and Predictive Value of <i>LIV1</i> Expression in Early Breast Cancer and by Molecular Subtype

Background: LIV1 is a transmembrane protein that may become a new therapeutic target through the development of antibody–drug conjugates (ADCs). Few studies are available regarding the assessment of <i>LIV1</i> expression in clinical breast cancer (BC) samples. Methods: We analyzed <i...

Full description

Bibliographic Details
Main Authors: Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceutics
Subjects:
LIV1
SLC39A6
ZIP6
breast cancer
antibody–drug conjugates
zinc transporter protein
Online Access:https://www.mdpi.com/1999-4923/15/3/938

Internet

https://www.mdpi.com/1999-4923/15/3/938

Similar Items